Further studies have shown that treatment with IL-6- or IL-8-enriched senescence CM induces a self- and cross-reinforced senescence/inflammatory milieu, rendering the otherwise less aggressive MCF-7 breast cancer cells stemness-enhanced [113], which was consistent with another study concerning the effect of IL-8 on MCF-7 breast cancer cells [125]. This evidence concerns the gene IL6 and breast carcinoma.